Renal function and injury pathways

Renal function and injury pathways refer to the integrated physiological processes and pathological signaling cascades that govern kidney health and the progression of renal disease. These pathways encompass a wide range of processes, including the regulation of glomerular filtration, tubular transport, and the activation of the renin-angiotensin-aldosterone system (RAAS) (Source: NIDDK). In the context of disease, injury pathways involve pro-inflammatory signaling (e.g., via NF-κB), oxidative stress, and pro-fibrotic cascades such as the TGF-β/Smad pathway, which lead to glomerulosclerosis and interstitial fibrosis (Source: Nature Reviews Nephrology). While the term does not describe a single molecular target, it serves as a framework for understanding how various drugs, such as ACE inhibitors and SGLT2 inhibitors, exert their nephroprotective effects by modulating specific nodes within these broader systems (Source: PubMed, PMC5491025). Therapeutic intervention in these pathways is critical for managing conditions like Chronic Kidney Disease (CKD) and Diabetic Nephropathy, where the goal is to slow the progression toward end-stage renal disease (Source: NEJM). Monitoring the activity and health of these pathways is typically achieved through clinical biomarkers such as serum creatinine, albuminuria, and emerging injury markers like KIM-1 (Source: CJASN).

Other names

Kidney injury pathwaysRenal signaling cascadesPathways of renal dysfunctionNephrotoxicity pathways

Modulation of specific molecular components within renal pathways, such as the renin-angiotensin system or sodium-glucose cotransporters, to reduce glomerular pressure, inflammation, and fibrosis.